"University"

During the past decade, Chulalongkorn University conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 5 clinical trials were completed, i.e. on average, 17.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chulalongkorn University" #1 sponsor was "Chulalongkorn University" with 26 trials, followed by "The HIV Netherlands Australia Thailand Research Collaboration" with 3 trials sponsored, "Takeda" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chulalongkorn University" #1 collaborator was "Chulalongkorn University" with 5 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator, "National Health Security Office, Thailand" with 2 trials as a collaborator, "National Research Council of Thailand" with 2 trials as a collaborator and "Asan Medical Center" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Chulalongkorn University" are "Acute Kidney Injury" (2 trials), "Brugada Syndrome" (2 trials), "Continuous Renal Replacement Therapy" (2 trials), "Obesity" (2 trials) and "Regional Citrate Anticoagulation" (2 trials). Many other conditions were trialed in "Chulalongkorn University" in a lesser frequency.

Most popular intervention types in "Chulalongkorn University" are "Drug" (24 trials), "Device" (5 trials), "Other" (4 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Enalapril plus Losartan" (2 trials), "0.9% NaCl solution" (1 trials), "3DTVUS : Uterine peristaltic frequencies" (1 trials) and "ACEI/ARB and corticosteroids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chulalongkorn University" are 43 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Chulalongkorn University". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Chulalongkorn University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Chulalongkorn University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 17 trials that are defined as “Not Applicable".

Chulalongkorn University has several departments that took part in Clinical trials: "Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital" - 10 trials, "Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity" - 6 trials, "Faculty of Sports Science, Chulalongkorn University" - 5 trials, "Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University" - 3 trials, "Faculty of Medicine Chulalongkorn University" - 30 trials, "Department of Pediatrics, Chulalongkorn University" - 2 trials, "Pediatric infectious diseases section, King Chulalongkorn Memorial hospital" - 2 trials